McCormick & Company Incorporated (MKC)

Rating: HOLD

HOLD (5-tier) · quality defensive · conviction: low

EPS basis for the forward P/E and all scenario multiples: consensus forward EPS (broker-adjusted, non-GAAP).

Methodology: Valuation triangulated across five independent anchors — Monte Carlo (Student-t + regime switching), an independent DCF, peer re-rating, a sum-of-parts, and a scenario-weighted PWEV. Figures reconciled to Alpha Vantage 2026-06-26. Each chart below sits with the part of the thesis it evidences.

General research for a skeptical institutional reader. Not personalised investment advice; no position sizing or trade instructions. Figures as of the analysis date; verify before acting.

Investment Committee Summary

📎 Download the full model (Excel) — DCF line items, scenarios, sensitivity, assumptions, and extended fundamentals.

Rating Bridge

Rating = HOLD because:

• Probability-weighted scenario value implies -5% vs spot
• Monte Carlo median implies -13% vs spot
• DCF fair value implies -50% vs spot — but this is terminal-value sensitive (exit-multiple $26 vs Gordon $37, 40% apart), so it carries less weight
• Bear case (Structural — GLP-1 / Private-Label Erosion) downside is -59% vs spot
• Net: reward/risk of 0.4× is not asymmetric enough for a Buy and not impaired enough for a Sell — hence Hold.

Investment Thesis

At $50.42 on 16.3x forward earnings, the market prices McCormick as a defensive staple whose branded flavour franchise holds share and grows earnings low-single-digit. That is close to fair. The engine's base case sees Packaged Foods at 2% growth and a 15.4% operating margin, producing roughly $3.26 of EPS and a $54.98 target on a 16.85x multiple; the probability-weighted target of $49.60 sits just below spot. The five anchors triangulate tightly — the DCF fair value of $27.78 is far lower because a 0.073 incremental return on the capex ramp barely clears the 8% cost of capital, while the peer forward-P/E median implies $51.34. The gap between a modest earnings model and a demanding DCF is the reason the rating is HOLD rather than BUY: buyers pay a quality multiple for growth the cash-flow math does not yet reward. The single most damaging risk is structural volume loss to GLP-1 appetite suppression and private-label trade-down, which would break the price/mix-offsets-volume assumption the whole base case rests on.

The dashboard below is the whole argument on one page: spot ($52) against each valuation anchor, the scenario tree, technicals and the options-implied move.

Anti-Thesis (The Real Bear Case)

The highest-probability bear mechanism is structural, not cyclical. GLP-1 adoption durably suppresses snacking and centre-store consumption while grocers expand private-label spice and seasoning lines that undercut McCormick on price. Volume then declines rather than merely softening, and price/mix can no longer offset it without accelerating the trade-down. Operating margin compresses toward 12.8% as fixed manufacturing and the newer capacity ramp deleverage, and the market re-rates a shrinking staple from 16x toward a distressed 8x. On that path EPS falls to roughly $2.63 and the target is $21.28, below the $44.82 fifty-two-week low. With ~$4.74bn of net debt, a weaker earnings base also pressures the buyback and dividend that support the equity story.

Key Debate

Gross Margin explains 50% of Monte Carlo outcome variance — the single variable that decides which side is right.

Earnings-Call Disconfirmation & Sentiment

Derived signals from the MCH market-data store (Alpha Vantage transcripts + news). Quantitative tone only — a disconfirmation flag, not a substitute for reading the call.

Management vs analyst tone (2026Q2): management +0.54 vs analyst floor +0.00 → delta +0.54 (n=25 mgmt / 24 Q&A; 80th pctile across the S&P book, z +0.9).

Flag: TYPICAL — management-vs-analyst tone within the normal cross-sectional range.

News (last 365d, 744 articles): avg ticker sentiment +0.11 (bullish 16% / bearish 3%)

Scenario Analysis

The tree runs from a structural 'Structural — GLP-1 / Private-Label Erosion' downside ($21) to a 'Bull — Margin Recovery / Re-Rate' bull case ($86); the probability-weighted blend (PWEV $50) is -5% versus spot.

Scenario rationale — what each probability buys (the driver path behind every target):

• Structural — GLP-1 / Private-Label Erosion (24%, $21). Structural impairment — GLP-1 / private-label erosion: earnings AND the multiple compress together. Target sits below the 52-week low by construction. Drivers — implied_target: 21.28; probability: 0.24.
• Volume / Cost Recession (18%, $40). Cyclical downturn — packaged-food volume + price/mix vs private-label + GLP-1 + input costs weakens for 1–2 years before normalising. Drivers — implied_target: 40.58; probability: 0.18.
• Base — Price/Mix Offsets Volume (32%, $55). Mid-cycle — normalised packaged-food volume + price/mix vs private-label + GLP-1 + input costs; disciplined capital allocation; steady returns. Drivers — implied_target: 54.98; probability: 0.32.
• Growth — Snacking + Premiumization (18%, $70). Upside — snacking + premiumization + margin recovery lifts earnings above mid-cycle; the multiple expands modestly. Drivers — implied_target: 70.6; probability: 0.18.
• Bull — Margin Recovery / Re-Rate (8%, $86). Upside tail — sustained tight conditions or a structural re-rate on snacking + premiumization + margin recovery. Drivers — implied_target: 86.1; probability: 0.08.

Valuation Triangulation

Five anchors — but read them with their basis in mind. The Monte Carlo, the DCF terminal, and the peer re-rate all key off a market multiple, so they are not fully independent; only the discounted cash flows themselves are genuinely multiple-free. The discipline is to read the spread and weight the cash-based view, not to treat five numbers as five independent votes.

Peer EV/Revenue re-rate — 0% weight: it duplicates the peer-multiple information already carried by the Peer P/E anchor while ignoring margin mix; weighting both would double-count the peer view. Shown as a cross-check.

Rating vs blend — the key debate. The rating tracks the multiple-discipline fair value (Monte Carlo $46 + scenario PWEV $50, ≈ spot); the weighted blend $40 (-24%) sits below it because the cash-flow DCF ($26) is materially more conservative than the market multiple. Whether the current multiple is justified is the central question for this name — and the principal downside risk to the rating.

Monte Carlo — the distribution, not a point

10,000 paths, Student-t shocks (fat tails) with a regime-switching overlay. The median lands at $46 and 38% of paths finish above spot. The variance decomposition shows the gross margin is the dominant swing factor (50% of variance). The fundamental driver, not the multiple, sets the spread — a cleaner setup.

DCF — the cash-flow anchor

Independent of the market multiple: a 5-year path, WACC 8.0%, 14x terminal FCF multiple → $26. This anchor is deliberately the heaviest (41%): it is the valuation least hostage to the current multiple regime.

Peer benchmarking — relative value

Against the peer cohort, re-rating to the peer-median forward multiple (P/E 16.56x) implies $51. A premium is only justified by superior growth/margins; otherwise it is multiple risk. Weighted just 12% so the market's mood does not drive the fair value.

Across all anchors the spread is 55% of the median — wide (genuine disagreement — the blend carries low valuation confidence).

Revenue-Segment Breakdown

The company-specific drivers behind the valuation — each segment carries its own growth, margin, multiple and capex intensity. (Tags: FACT reported · ESTIMATE from disclosures · INFERENCE judgment.)

Named Exposures

Demand & pricing cycle (FACT/ESTIMATE)

Capital intensity & shareholder returns (ESTIMATE)

Structural risk vs optionality (INFERENCE)

Industry Context — Consumer Staples — Food Bev

This name sits in the Consumer Staples — Food Bev as a packaged_food. packaged-food volume + price/mix vs private-label + GLP-1 + input costs Its scenarios are not guessed in isolation — they inherit a single, shared view of the cluster's driver cycle, so the names that depend on the same event are mutually consistent.

Value chain: KO (beverages) · PEP (beverages) · MNST (beverages) · MDLZ (packaged_food) · KDP (beverages) · HSY (packaged_food) · KHC (packaged_food) · GIS (packaged_food) · HRL (packaged_food) · MKC (packaged_food) · SJM (packaged_food) · CAG (packaged_food)

Mapping note: name-level 'Structural — GLP-1 / Private-Label Erosion' (24%) + 'Volume / Cost Recession' (18%) map to cluster Structural — GLP-1 / Private-Label Volume Hit (42%); name-level 'Growth — Snacking + Premiumization' (18%) + 'Bull — Margin Recovery / Re-Rate' (8%) map to cluster Upside — Premiumization / EM Growth (26%) — the cluster row is the SUM of the mapped scenario probabilities, not a different estimate.

On the cluster's key downside — Structural — GLP-1 / Private-Label Volume Hit () — this name implies 42% vs the cluster house view of 40% (in line with the house). The cluster's full cross-stock reconciliation governs that the names which ride the same capex cycle assign it comparable odds.

Structure: Shared State — The staples_food_bev cycle is the shared macro driver. Driver — food & beverage volume + price/mix vs private-label + GLP-1 + input costs Dispersion — Members differ by cyclicality (quality compounders vs deep cyclicals).

Model Appendix

DCF — line items

FCF is bridged: NOPAT + D&A − Capex − ΔNWC (capex intensity 4% of revenue, weighted from the segments) — not a single conversion fudge.

WACC 8.0% · Σ PV(FCF) $3B + PV(terminal) $9B = EV $12B; + net cash → equity $7B ÷ diluted shares 0.27B = $26/share (exit-multiple terminal).

• Gordon (perpetuity-growth) terminal at 2.5% → $37/share — a genuinely non-multiple, cash-based cross-check; the exit-multiple and Gordon values bracket the terminal-value risk.
• Incremental ROIC on the forecast capex ≈ 7% vs WACC 8% → below WACC — the incremental build is value-dilutive.

Peer set

Peer-median fwd P/E → $51; EV/Rev → $39.

Weighted fair-value math

Sensitivity

DCF/share — WACC × terminal multiple

DCF/share — revenue CAGR Δ × op-margin Δ

Tornado — DCF/share swing by driver (widest first)

Company lever — SoP/share vs Packaged Foods multiple (AI re-rating) (base 16x)

Consensus & Market Expectations

_Consensus figures: Alpha Vantage sell-side aggregates. Where the house view sits materially above or below the street, the divergence is itself a datum — see the thesis.

Balance Sheet & Liquidity

Balance-sheet data as of 2025-11-30 (Alpha Vantage).

Capital Allocation

Free-Cash-Flow Quality

Accounting quality: SBC 0.6% of revenue; cash conversion (OCF/NI) 122% — cash-backed.

Catalyst Calendar

• 2026-10-01 (~85d) — FY2026 (Nov year-end) volume-inflection print / FY2027 guide (authored)
• 2026-11-15 (~130d) — Cost-savings program (CCI) run-rate update (authored)
• 2027-01-15 (~191d) — Flavor Solutions new-customer / reformulation win cadence (authored)

Forecast Track Record

• EPS surprise: beat 75.0% of the last 8 quarters; average surprise +7.1%.

Competitive Moat

Narrow moat. McCormick's edge is brand share, shelf-space incumbency and flavour-formulation IP in Flavor Solutions - real but eroding at the margin; if private-label spice and GLP-1-driven volume decline compress the branded premium, the ~16x forward multiple is fair-to-rich and the terminal multiple should sit near the staples group, not above it.

Moat sources:

• Leading branded share in US spices/seasonings with shelf-space incumbency
• Flavor Solutions B2B formulation IP and customer switching costs (reformulation risk)
• Scale in flavour R&D and global sourcing/distribution
• Eroding pricing umbrella as grocers expand private-label spice lines

Regulatory & Legal Risk

Probabilities and sensitivities are analyst estimates, not market-implied.

Scenario Macro & Key Risks

What the Market Is Pricing In

At the current price, the market pays 15.8× forward EPS, vs the house DCF terminal 14.0×, and a peer median 16.56×. The house DCF sits 50% below spot, so the market is pricing in more than the house case — roughly 3.3pp of revenue CAGR.

Variant perception: the house view is below-consensus, and the thesis is primarily event-driven.

Peer Quality & Weighting

Quality-weighted forward P/E: 16.5× (simple median 16.56×). Direct peers count 100%, segment 50%, broad 25%.

Historical-range cross-check: 52-week range $45–$76, centre $58 (+12% vs spot); spot sits at the 24th percentile of the range. Low-weight mean-reversion cross-check, not a fundamental anchor.

Risk / Reward & Margin of Safety

Reward/risk compares triangulated upside against the probability-weighted bear target, not the extreme tail. Bull case (Bull — Margin Recovery / Re-Rate): $86.

Assumption Register

Sensitivity-ranked drivers (widest fair-value swing first): Op margin ±3pp (18.0); Revenue CAGR ±3pp (12.0); Terminal × ±15% (9.0); Capex intensity ±15% (5.0); WACC ±1pp (4.0).

Inputs, Sources & Confidence

Every load-bearing input, labelled by type and confidence. (reported fact · company guidance · consensus estimate · market data · house estimate · inference.)

Source Log

Citation coverage: 13/14 mandated claims sourced. Filing URLs are not available via the market-data provider; company statements are cited as 10-K/10-Q via Alpha Vantage.

Load-Bearing Assumptions

DCF: WACC 8%, terminal multiple 14×, FY+5 revenue $8B. Triangulation leans 41% on DCF, 29% on PWEV.

Reasons the Thesis Could Fail (Falsifiable)

Pre-registered signals that would break the thesis — each polices a specific scenario boundary and is checked at every earnings update:

• Organic volume growth (consolidated) < -0.02 (2 consecutive prints → Structural — GLP-1 / Private-Label Volume Hit). Volume falling more than 2% for two quarters would confirm GLP-1 and private-label share loss the base case assumes price/mix can offset.
• Adjusted operating margin < 0.14 (2 consecutive prints → Volume / Cost Recession). Margin sustained below 14% sits between the base (15.4%) and the volume/cost-recession path (14.8%), signalling input-cost drag is not being recovered.
• Consumer segment organic sales growth < 0.0 (2 consecutive prints → Structural — GLP-1 / Private-Label Volume Hit). A branded-consumer franchise going ex-growth removes the premiumisation offset and points at the structural path rather than a cyclical dip.
• Gross margin < 0.37 (2 consecutive prints → Volume / Cost Recession). Gross margin below the high-30s for two quarters shows commodity, packaging and freight costs outrunning pricing, the mechanism behind margin compression.
• Full-year adjusted EPS guidance < 2.9 (single event → Base — Price/Mix Offsets Volume). A guide cut below roughly $2.90 would fall short of the base-case EPS (~$3.26) and validate the lower-growth, lower-margin paths.
• Net leverage (net debt / EBITDA) > 3.5 (2 consecutive prints → Structural — GLP-1 / Private-Label Volume Hit). Leverage climbing above 3.5x on the ~$4.74bn net-debt base would constrain the buyback and dividend the shareholder-return case depends on.

Fact / Inference / Speculation

• FACT: Spot $52; 52-week range $45–$76; engine rating HOLD; base-case target $50 (-5%). (source: Alpha Vantage 2026-06-26, 8 July 2026)
• INFERENCE: Triangulated FV $40 (-24% vs spot · triangulated FV); the rating tracks the Monte-Carlo + scenario-PWEV core; the cash-flow anchor sits below the multiple-discipline core.
• SPECULATION: At current prices the embedded bet is that Gross Margin keeps surprising favourably — an operating call the next two prints will test.

Recommendation: HOLD

Balanced: triangulated fair value $40 (-24% vs spot); the outcome hinges on Gross Margin. The debate is Gross Margin — a fundamental call.

Disclosures & Limitations

This report is for informational and research purposes only. It is not personalised investment advice and does not consider any investor's objectives, financial situation, risk tolerance, tax position, or liquidity needs.

• No suitability assessment has been performed for any individual.
• Market data may be delayed or inaccurate; figures are as of the analysis date.
• Model outputs (fair values, targets, scenario probabilities) are estimates and may be wrong.
• Forecasts are uncertain; past performance is not indicative of future returns.
• The author or publisher may hold positions in securities mentioned.
• Users should verify information against primary sources (company filings) before acting.
• Investing involves risk of loss; there is no guarantee any target price is achieved.
• Ratings follow a defined research methodology (12-month expected-return thresholds), not individual circumstances.